Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis

American Journal of Pathology

Volumn 156, Issue 4, 2000, Pages 1217-1225

  Levy, Gary A ^a   Liu, Mingfeng ^a   Ding, Jinwen ^a   Yuwaraj, Shankary ^a   Leibowitz, Julian ^b   Marsden, Philip A ^a   Ning, Qin ^a   Kovalinka, Ana ^a   Phillips, M James ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; COMPLEMENTARY DNA; PROTHROMBIN;

ANIMAL CELL; ARTICLE; CHO CELL; ENZYME ACTIVITY; GENE EXPRESSION; LIVER DISEASE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 0033839077     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64992-9     Document Type: Article

References (43)

1. Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity
2. Murine hepatitis virus: Molecular biology and pathogenesis
3. Fulminant hepatic failure in murine hepatitis virus strain 3 infection: Tissue-specific expression of a novel fgl2 prothrombinase
4. Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection
5. Sequence of a human transcript expressed in T-lymphocytes and encoding a fibrinogen-like protein
6. Structural organization of the human neuronal nitric oxide synthase gene (NOS1)
7. 16,16-dimethyl prostaglandin E2 prevents the development of fulminant hepatitis, and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection
8. Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase
9. Isolation of the hepatic pericanalicular contractile apparatus: Actin filaments and myosin II motor with the surrounding intermediate filament sheath
10. IL-6 and NF-IL6 in acute-phase response and viral infection
11. Regulation of nuclear transcription factors by stress signals
12. Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection
13. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th 1 cytokine production but inhibits Th2 cytokine response
14. The effect of mouse hepatitis virus infection on the microcirculation of the liver
15. Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3
16. Pattern of disease after murine hepatitis strain 3 infection correlates with macrophage activation and not viral replication
17. Susceptibility/resistance to mouse hepatitis virus strain 3, and macrophage procoagulant activity are genetically linked, and controlled by two non-H-2-linked genes
18. The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene
19. Recovery from Hemophilia B Leyden: An androgen-responsive element in the Factor IX promoter
20. The 5'-sequence of human Factor XII gene contains transcription regulatory elements typical of liver specific, estrogen-modulated genes
21. Liver-specific expression of the gene coding for human Factor X, a blood coagulation factor
22. Viral versus toxic hepatic necrosis
23. Early and intensive therapy for intravascular coagulation in acute liver failure
24. Hepatic sinusoidal cell destruction in the development of intravascular coagulation in acute liver failure of rats
25. Accumulation and cellular localization of fibrinogen/fibrin during short term and long-term rat liver injury
26. Expression of the thrombin receptor in human liver: Up-regulation during acute and chronic injury
27. Shock and tissue injury induced by recombinant human cachectin
28. Cachectin/tumor necrosis factor induces lethal shock, and stress hormone responses in the dog
29. Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents
30. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension and hypothermia of Gram-negative sepsis
31. The pathobiology of viral hepatitis and immunologic activation of the coagulation protease network
32. A pathological study of fulminant hepatic disease
33. Structure of a cytotoxic T lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains
34. Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes
35. Presence of a vertebrate fibrinogen-like sequence in an echinoderm
36. Tenascin, an extracellular matrix protein, exerts immunomodulatory activities
37. Intrinsic membrane protein structure: Principles and predictions
38. The coagulation cascade: Initiation, maintenance and regulation
39. A detailed consideration of principal domain of vertebrae fibrinogen and its relatives
40. Molecular cloning and initial characterization of a novel fibrinogen related gene, HFREP-1
41. Molecular cloning and characterization of ficolin, a multimeric protein with fibrinogen- and collagen-like domains